Immunotherapy, Adoptive
Form of adoptive transfer where cells with antitumor activity are transferred to the tumor-bearing host in order to mediate tumor regression. The lymphoid cells commonly used are lymphokine-activated killer (LAK) cells and tumor-infiltrating lymphocytes (TIL). This is usually considered a form of passive immunotherapy. (From DeVita, et al., Cancer, 1993, pp.305-7, 314)
Year introduced: 1991
PubMed search builder options
Subheadings:
Tree Number(s): E02.095.465.425.400.330.050.400, E05.478.550.520.050.400
MeSH Unique ID: D016219
Entry Terms:
- Cellular Immunotherapy, Adoptive
- Adoptive Cellular Immunotherapies
- Cellular Immunotherapies, Adoptive
- Immunotherapies, Adoptive Cellular
- Immunotherapy, Adoptive Cellular
- Adoptive Cellular Immunotherapy
- Adoptive Immunotherapy
- Adoptive Immunotherapies
- Immunotherapies, Adoptive
- Chimeric Antigen Receptor Therapy
- CAR T-Cell Therapy
- CAR T-Cell Therapies
- CAR T Cell Therapy
- T-Cell Therapies, CAR
- T-Cell Therapy, CAR
- Therapies, CAR T-Cell
- Therapy, CAR T-Cell
Previous Indexing:
See Also: